Hodgkin's Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma
Conditions:   Hodgkin Lymphoma, Adult;   Relapse;   Refractory Hodgkin Lymphoma Intervention:   Drug: PD-1 inhibitor Sponsor:   Institute of Hematology & Blood Diseases Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2021 Category: Research Source Type: clinical trials

Connect ® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
Conditions:   Lymphoma, Non-Hodgkin;   Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Follicular;   Lymphoma, B-Cell Intervention:   Sponsor:   Celgene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials